Self-reported cognitive problems in testicular cancer patients: Relation to neuropsychological performance, fatigue, and psychological distress

Journal of Psychosomatic Research

Volumn 70, Issue 5, 2011, Pages 403-410

  Skaali, Tone ^a,b   Fosså, Sophie D ^a,b   Andersson, Stein ^a   Cvancarova, Milada ^a,b   Langberg, Carl W ^c   Lehne, Gustav ^a   Dahl, Alv A ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chemotherapy; Fatigue; Prospective study; Psychological distress; Self reported cognitive problems; Testicular cancer patients

Indexed keywords

ANTINEOPLASTIC AGENT;

ACROCYANOSIS; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; COGNITIVE DEFECT; CONCENTRATION LOSS; CONTROLLED STUDY; DISTRESS SYNDROME; EDUCATION; FATIGUE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; ORCHIECTOMY; PROSPECTIVE STUDY; QUESTIONNAIRE; TESTIS CANCER;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; COGNITION DISORDERS; FATIGUE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORCHIECTOMY; PERSONALITY; QUALITY OF LIFE; QUESTIONNAIRES; SELF REPORT; STRESS, PSYCHOLOGICAL; TESTICULAR NEOPLASMS;

EID: 79954897801     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2010.12.004     Document Type: Article

References (38)

1. Kohli S, Griggs JJ, Roscoe JA, Jean-Pierre P, Bole C, Mustian KM, et al. Self-reported cognitive impairment in patients with cancer. J Oncol Pract 2007, 3:54-59.
2. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008, 19:623-629.
3. Vardy J, Tannock I Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 2007, 63:183-202.
4. Vodermaier A Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments. Women's Health (Lond Engl ) 2009, 5:503-516.
5. Wefel JS, Witgert ME, Meyers CA Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev 2008, 18:121-131.
6. Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006, 94:828-834.
7. Shilling V, Jenkins V Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 2007, 11:6-15.
8. Downie FP, Mar Fan HG, Houede-Tchen N, Yi Q, Tannock IF Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psychooncology 2006, 15:921-930.
9. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007, 109:1905-1913.
10. Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, et al. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 2007, 66:108-118.
11. Debess J, Riis JO, Engebjerg MC, Ewertz M Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat 2010, 121:91-100.
12. Hermelink K, Kuchenhoff H, Untch M, Bauerfeind I, Lux MP, Buhner M, et al. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology 2010, 19:1321-1328.
13. Vardy J, Rourke S, Tannock IF Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007, 25:2455-2463.
14. Fossa SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, et al. Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol 2003, 21:1107-1118.
15. Schagen SB, Boogerd W, Muller MJ, Huinink WT, Moonen L, Meinhardt W, et al. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol 2008, 47:63-70.
16. Skaali T, Fossa SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, et al. A prospective study of neuropsychological functioning in testicular cancer patients. Ann Oncol 2010, published online Nov 3, 2010. 10.1093/annonc/mdq553.
17. Peckham M Testicular cancer. Acta Oncol 1988, 27:439-453.
18. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008, 53:478-496.
19. Horowitz M, Wilner N, Alvarez W Impact of Event Scale - Measure of subjective stress. Psychosom Med 1979, 41:209-218.
20. Sundin EC, Horowitz MJ Impact of Event Scale: psychometric properties. Br J Psychiatry 2002, 180:205-209.
21. Tuinman MA, Hoekstra HJ, Sleijfer DT, Fleer J, Vidrine DJ, Gritz ER, et al. Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy. Support Care Cancer 2007, 15:279-286.
22. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res 1993, 37:147-153.
23. Oldenburg J, Fossa SD, Dahl AA Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors. Qual Life Res 2006, 15:791-800.
24. Eysenck HJ, Eysenck SBG Manual of the EPQ 1975, Hodder and Stoughton, London.
25. Eysenck SBG, Tambs K Cross-cultural comparison of personality: Norway and England. Scand J Psychol 1990, 31:191-197.
26. Ewing JA Detecting alcoholism. The CAGE questionnaire. JAMA 1984, 252:1905-1907.
27. Aertgeerts B, Buntinx F, Kester A The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. J Clin Epidemiol 2004, 57:30-39.
28. Nelson HE, Willison JR The National Adult Reading Test - Test Manual (2nd edition) 1991, NFER-Nelson, Windsor.
29. Vaskinn A, Sundet K Estimation of premorbid IQ: a Norwegian version of the National Adult Reading Test. Tidsskr Nor Psykol Foren 2001, 38:1133-1140. [Article in Norwegian].
30. Sahakian BJ, Owen AM Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 1992, 85:399-402.
31. Cambridge Cognition CANTAB Eclipse Test Administration Guide 2005, Cambridge Cognition Limited, Cambridge, UK.
32. Brandt J, Benedict R Hopkins Verbal Learning Test - Revised. Professional manual 2001, Psychological Assessment Resources, Inc, Lutz, FL.
33. Reitan RM, Wolfson D The Halstead-Reitan Neuropsychological Test Battery. Theory and Clinical Interpretation 1993, Neuropsychology Press, Tucson, AZ. 2nd ed.
34. Delis DC, Kaplan E, Kramer JH, Ober BA California Verbal Learning Test - Second Edition (CVLT II). Manual 2000, Psychological Corporation, San Antonio.
35. Ruff RM, Light RH, Parker SB, Levin HS Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol 1996, 11:329-338.
36. Ouimet LA, Stewart A, Collins B, Schindler D, Bielajew C Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models. J Clin Exp Neuropsychol 2009, 31:73-89.
37. Schagen SB, Das E, van Dam FS The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psychooncology 2009, 18:674-678.
38. Fossa SD, Oldenburg J, Dahl AA Short- and long-term morbidity after treatment for testicular cancer. BJU Int 2009, 104:1418-1422.